Lung-only metastatic pancreatic cancer: Differences in patients ‘characteristics, molecular profile and survival

This publication has 24 references indexed in Scilit:

• Defying the odds: Outstanding survival in lung-only pancreatic cancer treated by Trifluridine-Tipiracil
  European Journal of Cancer, 2024
• Precision medicine for KRAS wild-type pancreatic adenocarcinomas
  European Journal of Cancer, 2023
• NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
  The Lancet, 2023
• CT features of lung metastases from pancreatic adenocarcinoma: Correlation with histopathologic findings
  Diagnostic and Interventional Imaging, 2021
• Metastases or primary recurrence to the lung is related to improved survival of pancreatic cancer as compared to other sites of dissemination. Results of a systematic review with meta-analysis
  European Journal of Surgical Oncology, 2020
• Pancreatic cancer
  The Lancet, 2020
• Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma
  JAMA Surgery, 2019
• Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer
  Pancreatology, 2016
• Molecular Pathogenesis of Pancreatic Cancer
  2016
• The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas
  Journal of Surgical Oncology, 2015